Charles M. Baum - Jan 20, 2023 Form 4 Insider Report for Mirati Therapeutics, Inc. (MRTX)

Role
President,Founder,Head of R&D, Director
Signature
/s/ Reena R. Desai, Attorney-in-Fact
Stock symbol
MRTX
Transactions as of
Jan 20, 2023
Transactions value $
$0
Form type
4
Date filed
1/24/2023, 03:20 PM
Previous filing
Jan 5, 2023
Next filing
Jun 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Award $0 +4.44K +2.63% $0.00 173K Jan 20, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRTX Employee Stock Option (Right to Buy) Award $0 +7.52K $0.00 7.52K Jan 20, 2023 Common Stock 7.52K $45.66 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of Restricted Stock Units (RSUs). Shares will vest 100% on the anniversary of the grant date.
F2 The shares subject to the Option vest and become exercisable in 12 equal monthly installments following the date of grant.